FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313256783> ?p ?o ?g. }

• W4313256783 endingPage "197" @default.
• W4313256783 startingPage "188" @default.
• W4313256783 abstract "The integration of immune checkpoint inhibitors (ICI) for the treatment of melanoma has resulted in remarkable and durable responses. Given the potential role of immunosenescence, age may contribute to differential ICI efficacy and toxicity. While older patients have been studied in detail, outcomes from ICI in young patients (≤40 years) are not well characterised.We performed a multi-institutional, retrospective study of patients with advanced melanoma treated with anti-PD-1 monotherapy or ICI combination (ipilimumab and anti-PD-1). Response rates, survival, and toxicities were examined based on age comparing those under 40 years of age with older patients (age 41-70 and ≥ 71 years).A total of 676 patients were included: 190 patients (28%) aged ≤40 years, 313 (46%) between ages 41-70, and 173 patients (26%) aged ≥71. Patients ≤40 years had higher response rates (53% vs 38%, p = 0.035) and improved progression-free survival (median 13.7 vs 4.0 months, p = 0.032) with combination ICI compared to monotherapy. Progression-free survival was similar among groups while overall survival was inferior in patients >70 years, who had low response rates to combination therapy (28%). ICIs had a similar incidence of severe toxicities, though hepatotoxicity was particularly common in younger patients vs. patients >40 with monotherapy (9% vs. 2%, p = 0.007) or combination ICI (37% vs. 10%, p < 0.001).ICIs had comparable efficacy between younger and older patients, although outcomes were superior with combination ICI compared to monotherapy in patients aged ≤40 years. Toxicity incidence was similar across age groups, though organs affected were substantially different." @default.
• W4313256783 created "2023-01-06" @default.
• W4313256783 creator A5008479799 @default.
• W4313256783 creator A5011332633 @default.
• W4313256783 creator A5013399740 @default.
• W4313256783 creator A5018914026 @default.
• W4313256783 creator A5022162371 @default.
• W4313256783 creator A5022520811 @default.
• W4313256783 creator A5024199382 @default.
• W4313256783 creator A5025067315 @default.
• W4313256783 creator A5026315001 @default.
• W4313256783 creator A5031050940 @default.
• W4313256783 creator A5031863894 @default.
• W4313256783 creator A5034365278 @default.
• W4313256783 creator A5049229784 @default.
• W4313256783 creator A5057381405 @default.
• W4313256783 creator A5058294413 @default.
• W4313256783 creator A5059961435 @default.
• W4313256783 creator A5062892205 @default.
• W4313256783 creator A5063982755 @default.
• W4313256783 creator A5064875028 @default.
• W4313256783 creator A5064923908 @default.
• W4313256783 creator A5066489948 @default.
• W4313256783 creator A5067101751 @default.
• W4313256783 creator A5068684456 @default.
• W4313256783 creator A5071577704 @default.
• W4313256783 creator A5077773795 @default.
• W4313256783 creator A5082069377 @default.
• W4313256783 creator A5083061830 @default.
• W4313256783 creator A5087049625 @default.
• W4313256783 creator A5089113899 @default.
• W4313256783 creator A5085551324 @default.
• W4313256783 date "2023-03-01" @default.
• W4313256783 modified "2023-10-18" @default.
• W4313256783 title "Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma" @default.
• W4313256783 cites W2301707196 @default.
• W4313256783 cites W2610766845 @default.
• W4313256783 cites W2655262992 @default.
• W4313256783 cites W2747774814 @default.
• W4313256783 cites W2794627893 @default.
• W4313256783 cites W2796929908 @default.
• W4313256783 cites W2808441345 @default.
• W4313256783 cites W2912365504 @default.
• W4313256783 cites W2945590213 @default.
• W4313256783 cites W2947554843 @default.
• W4313256783 cites W3006664585 @default.
• W4313256783 cites W3008444406 @default.
• W4313256783 cites W3021418236 @default.
• W4313256783 cites W3021590305 @default.
• W4313256783 cites W3026275561 @default.
• W4313256783 cites W3043703771 @default.
• W4313256783 cites W3085427829 @default.
• W4313256783 cites W3086473620 @default.
• W4313256783 cites W3126577181 @default.
• W4313256783 cites W3130701560 @default.
• W4313256783 cites W4210731482 @default.
• W4313256783 cites W4211208194 @default.
• W4313256783 cites W4225394054 @default.
• W4313256783 cites W4226258201 @default.
• W4313256783 doi "https://doi.org/10.1016/j.ejca.2022.12.013" @default.
• W4313256783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36680880" @default.
• W4313256783 hasPublicationYear "2023" @default.
• W4313256783 type Work @default.
• W4313256783 citedByCount "1" @default.
• W4313256783 countsByYear W43132567832023 @default.
• W4313256783 crossrefType "journal-article" @default.
• W4313256783 hasAuthorship W4313256783A5008479799 @default.
• W4313256783 hasAuthorship W4313256783A5011332633 @default.
• W4313256783 hasAuthorship W4313256783A5013399740 @default.
• W4313256783 hasAuthorship W4313256783A5018914026 @default.
• W4313256783 hasAuthorship W4313256783A5022162371 @default.
• W4313256783 hasAuthorship W4313256783A5022520811 @default.
• W4313256783 hasAuthorship W4313256783A5024199382 @default.
• W4313256783 hasAuthorship W4313256783A5025067315 @default.
• W4313256783 hasAuthorship W4313256783A5026315001 @default.
• W4313256783 hasAuthorship W4313256783A5031050940 @default.
• W4313256783 hasAuthorship W4313256783A5031863894 @default.
• W4313256783 hasAuthorship W4313256783A5034365278 @default.
• W4313256783 hasAuthorship W4313256783A5049229784 @default.
• W4313256783 hasAuthorship W4313256783A5057381405 @default.
• W4313256783 hasAuthorship W4313256783A5058294413 @default.
• W4313256783 hasAuthorship W4313256783A5059961435 @default.
• W4313256783 hasAuthorship W4313256783A5062892205 @default.
• W4313256783 hasAuthorship W4313256783A5063982755 @default.
• W4313256783 hasAuthorship W4313256783A5064875028 @default.
• W4313256783 hasAuthorship W4313256783A5064923908 @default.
• W4313256783 hasAuthorship W4313256783A5066489948 @default.
• W4313256783 hasAuthorship W4313256783A5067101751 @default.
• W4313256783 hasAuthorship W4313256783A5068684456 @default.
• W4313256783 hasAuthorship W4313256783A5071577704 @default.
• W4313256783 hasAuthorship W4313256783A5077773795 @default.
• W4313256783 hasAuthorship W4313256783A5082069377 @default.
• W4313256783 hasAuthorship W4313256783A5083061830 @default.
• W4313256783 hasAuthorship W4313256783A5085551324 @default.
• W4313256783 hasAuthorship W4313256783A5087049625 @default.
• W4313256783 hasAuthorship W4313256783A5089113899 @default.
• W4313256783 hasConcept C120665830 @default.
• W4313256783 hasConcept C121332964 @default.

• next